Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC.
Thomas LongvalAnne-Claire LeprêtreAurélie RavinetAmandine FayardEdouard ForcadeTereza ComanRabah RedjoulAna BerceanuNimrod BuchbinderGuillaume BerlieMaria MappouraFederica GiannottiFlorian ChevillonMarie RobinRégis Peffault de LatourFlore Sicre de Fontbrunenull nullPublished in: Bone marrow transplantation (2024)